ID   PCAT1_HUMAN             Reviewed;         534 AA.
AC   Q8NF37; Q1HAQ1; Q7Z4G6; Q8N3U7; Q8WUL8; Q9GZW6;
DT   25-JUL-2006, integrated into UniProtKB/Swiss-Prot.
DT   25-JUL-2006, sequence version 2.
DT   10-MAY-2017, entry version 126.
DE   RecName: Full=Lysophosphatidylcholine acyltransferase 1;
DE            Short=LPC acyltransferase 1;
DE            Short=LPCAT-1;
DE            Short=LysoPC acyltransferase 1;
DE            EC=2.3.1.23;
DE   AltName: Full=1-acylglycerophosphocholine O-acyltransferase;
DE   AltName: Full=1-alkylglycerophosphocholine O-acetyltransferase;
DE            EC=2.3.1.67;
DE   AltName: Full=Acetyl-CoA:lyso-platelet-activating factor acetyltransferase;
DE            Short=Acetyl-CoA:lyso-PAF acetyltransferase;
DE            Short=Lyso-PAF acetyltransferase;
DE            Short=LysoPAFAT;
DE   AltName: Full=Acyltransferase-like 2;
DE   AltName: Full=Phosphonoformate immuno-associated protein 3;
GN   Name=LPCAT1; Synonyms=AYTL2, PFAAP3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=16704971; DOI=10.1074/jbc.M600225200;
RA   Nakanishi H., Shindou H., Hishikawa D., Harayama T., Ogasawara R.,
RA   Suwabe A., Taguchi R., Shimizu T.;
RT   "Cloning and characterization of mouse lung-type acyl-
RT   CoA:lysophosphatidylcholine acyltransferase 1 (LPCAT1): expression in
RT   alveolar type II cells and possible involvement in surfactant
RT   production.";
RL   J. Biol. Chem. 281:20140-20147(2006).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 136-534.
RC   TISSUE=Spleen;
RX   PubMed=12693554; DOI=10.1093/dnares/10.1.49;
RA   Jikuya H., Takano J., Kikuno R., Hirosawa M., Nagase T., Nomura N.,
RA   Ohara O.;
RT   "Characterization of long cDNA clones from human adult spleen. II. The
RT   complete sequences of 81 cDNA clones.";
RL   DNA Res. 10:49-57(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 140-534.
RC   TISSUE=Eye;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 236-534.
RC   TISSUE=Teratocarcinoma;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 298-534.
RA   Liu Y., Cheng J., Lu Y.;
RT   "Screening and cloning of a new immuno-associated gene regulated by
RT   phosphonoformate.";
RL   Submitted (JUL-2002) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 448-534.
RC   TISSUE=Amygdala;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [7]
RP   IDENTIFICATION, AND FUNCTION.
RX   PubMed=16864775; DOI=10.1073/pnas.0604946103;
RA   Chen X., Hyatt B.A., Mucenski M.L., Mason R.J., Shannon J.M.;
RT   "Identification and characterization of a lysophosphatidylcholine
RT   acyltransferase in alveolar type II cells.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:11724-11729(2006).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [9]
RP   FUNCTION, CATALYTIC ACTIVITY, PATHWAY, SUBCELLULAR LOCATION, AND
RP   TOPOLOGY.
RX   PubMed=21498505; DOI=10.1074/jbc.M110.202424;
RA   Moessinger C., Kuerschner L., Spandl J., Shevchenko A., Thiele C.;
RT   "Human lysophosphatidylcholine acyltransferases 1 and 2 are located in
RT   lipid droplets where they catalyze the formation of
RT   phosphatidylcholine.";
RL   J. Biol. Chem. 286:21330-21339(2011).
RN   [10]
RP   FUNCTION.
RX   PubMed=25491198; DOI=10.1186/s12860-014-0043-3;
RA   Moessinger C., Klizaite K., Steinhagen A., Philippou-Massier J.,
RA   Shevchenko A., Hoch M., Ejsing C.S., Thiele C.;
RT   "Two different pathways of phosphatidylcholine synthesis, the Kennedy
RT   Pathway and the Lands Cycle, differentially regulate cellular
RT   triacylglycerol storage.";
RL   BMC Cell Biol. 15:43-43(2014).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
CC   -!- FUNCTION: Possesses both acyltransferase and acetyltransferase
CC       activities (PubMed:16864775, PubMed:21498505). Activity is
CC       calcium-independent (By similarity). Mediates the conversion of 1-
CC       acyl-sn-glycero-3-phosphocholine (LPC) into phosphatidylcholine
CC       (PC) (PubMed:21498505). Displays a clear preference for saturated
CC       fatty acyl-CoAs, and 1-myristoyl or 1-palmitoyl LPC as acyl donors
CC       and acceptors, respectively (PubMed:16704971). May synthesize
CC       phosphatidylcholine in pulmonary surfactant, thereby playing a
CC       pivotal role in respiratory physiology (PubMed:16864775). Involved
CC       in the regulation of lipid droplet number and size
CC       (PubMed:25491198). {ECO:0000250|UniProtKB:Q3TFD2,
CC       ECO:0000269|PubMed:16864775, ECO:0000269|PubMed:21498505,
CC       ECO:0000269|PubMed:25491198}.
CC   -!- CATALYTIC ACTIVITY: Acyl-CoA + 1-acyl-sn-glycero-3-phosphocholine
CC       = CoA + 1,2-diacyl-sn-glycero-3-phosphocholine.
CC       {ECO:0000269|PubMed:21498505}.
CC   -!- CATALYTIC ACTIVITY: Acetyl-CoA + 1-alkyl-sn-glycero-3-
CC       phosphocholine = CoA + 2-acetyl-1-alkyl-sn-glycero-3-
CC       phosphocholine. {ECO:0000269|PubMed:21498505}.
CC   -!- ENZYME REGULATION: Not activated by inflammatory stimulation.
CC       Inhibited by Cu(2+) and Fe(2+). Activity is not affected by
CC       Co(2+), Mg(2+) or Mn(2+) (By similarity). {ECO:0000250}.
CC   -!- PATHWAY: Lipid metabolism; phospholipid metabolism.
CC       {ECO:0000269|PubMed:21498505}.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000269|PubMed:21498505}; Single-pass type II membrane
CC       protein {ECO:0000269|PubMed:21498505}. Golgi apparatus membrane
CC       {ECO:0000269|PubMed:21498505}; Single-pass type II membrane
CC       protein {ECO:0000269|PubMed:21498505}. Lipid droplet
CC       {ECO:0000269|PubMed:21498505}. Note=May adopt a monotopic topology
CC       when embedded in the lipid monolayer of the lipid droplet, with
CC       both termini exposed to the cytoplasm.
CC       {ECO:0000269|PubMed:21498505}.
CC   -!- DOMAIN: The HXXXXD motif is essential for acyltransferase activity
CC       and may constitute the binding site for the phosphate moiety of
CC       the glycerol-3-phosphocholine. {ECO:0000250}.
CC   -!- DOMAIN: The di-lysine motif confers endoplasmic reticulum
CC       localization for type I membrane proteins. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the 1-acyl-sn-glycerol-3-phosphate
CC       acyltransferase family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAB14061.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=BAB14065.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB244719; BAE94688.1; -; mRNA.
DR   EMBL; AK090444; BAC03425.1; -; mRNA.
DR   EMBL; BC020166; AAH20166.3; -; mRNA.
DR   EMBL; AK022505; BAB14065.1; ALT_INIT; mRNA.
DR   EMBL; AK022499; BAB14061.1; ALT_INIT; mRNA.
DR   EMBL; AF530061; AAQ09945.1; -; mRNA.
DR   EMBL; AL831864; CAD38556.1; -; mRNA.
DR   CCDS; CCDS3864.1; -.
DR   RefSeq; NP_079106.3; NM_024830.4.
DR   UniGene; Hs.368853; -.
DR   ProteinModelPortal; Q8NF37; -.
DR   SMR; Q8NF37; -.
DR   BioGrid; 122973; 22.
DR   IntAct; Q8NF37; 8.
DR   STRING; 9606.ENSP00000283415; -.
DR   SwissLipids; SLP:000000295; -.
DR   iPTMnet; Q8NF37; -.
DR   PhosphoSitePlus; Q8NF37; -.
DR   SwissPalm; Q8NF37; -.
DR   BioMuta; LPCAT1; -.
DR   DMDM; 110815902; -.
DR   EPD; Q8NF37; -.
DR   MaxQB; Q8NF37; -.
DR   PaxDb; Q8NF37; -.
DR   PeptideAtlas; Q8NF37; -.
DR   PRIDE; Q8NF37; -.
DR   TopDownProteomics; Q8NF37; -.
DR   DNASU; 79888; -.
DR   Ensembl; ENST00000283415; ENSP00000283415; ENSG00000153395.
DR   Ensembl; ENST00000475622; ENSP00000423472; ENSG00000153395.
DR   GeneID; 79888; -.
DR   KEGG; hsa:79888; -.
DR   UCSC; uc003jcm.4; human.
DR   CTD; 79888; -.
DR   DisGeNET; 79888; -.
DR   GeneCards; LPCAT1; -.
DR   HGNC; HGNC:25718; LPCAT1.
DR   HPA; HPA012501; -.
DR   HPA; HPA022268; -.
DR   MIM; 610472; gene.
DR   neXtProt; NX_Q8NF37; -.
DR   OpenTargets; ENSG00000153395; -.
DR   PharmGKB; PA162394232; -.
DR   eggNOG; KOG4666; Eukaryota.
DR   eggNOG; ENOG410XSIQ; LUCA.
DR   GeneTree; ENSGT00390000004914; -.
DR   HOGENOM; HOG000234374; -.
DR   HOVERGEN; HBG060273; -.
DR   InParanoid; Q8NF37; -.
DR   KO; K13510; -.
DR   OMA; DYLYPDQ; -.
DR   OrthoDB; EOG091G09LH; -.
DR   PhylomeDB; Q8NF37; -.
DR   TreeFam; TF323244; -.
DR   BRENDA; 2.3.1.23; 2681.
DR   BRENDA; 2.3.1.51; 2681.
DR   Reactome; R-HSA-1482788; Acyl chain remodelling of PC.
DR   Reactome; R-HSA-1482925; Acyl chain remodelling of PG.
DR   Reactome; R-HSA-1483166; Synthesis of PA.
DR   Reactome; R-HSA-1483191; Synthesis of PC.
DR   Reactome; R-HSA-6798695; Neutrophil degranulation.
DR   Reactome; R-HSA-75109; Triglyceride Biosynthesis.
DR   UniPathway; UPA00085; -.
DR   ChiTaRS; LPCAT1; human.
DR   GenomeRNAi; 79888; -.
DR   PRO; PR:Q8NF37; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   Bgee; ENSG00000153395; -.
DR   CleanEx; HS_LPCAT1; -.
DR   Genevisible; Q8NF37; HS.
DR   GO; GO:0035577; C:azurophil granule membrane; TAS:Reactome.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:UniProtKB.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0005794; C:Golgi apparatus; ISS:UniProtKB.
DR   GO; GO:0000139; C:Golgi membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005811; C:lipid particle; IDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0003841; F:1-acylglycerol-3-phosphate O-acyltransferase activity; TAS:Reactome.
DR   GO; GO:0047184; F:1-acylglycerophosphocholine O-acyltransferase activity; IDA:UniProtKB.
DR   GO; GO:0047159; F:1-alkenylglycerophosphocholine O-acyltransferase activity; IEA:Ensembl.
DR   GO; GO:0047192; F:1-alkylglycerophosphocholine O-acetyltransferase activity; IEA:UniProtKB-EC.
DR   GO; GO:0047191; F:1-alkylglycerophosphocholine O-acyltransferase activity; IEA:Ensembl.
DR   GO; GO:0047144; F:2-acylglycerol-3-phosphate O-acyltransferase activity; TAS:Reactome.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:2001246; P:negative regulation of phosphatidylcholine biosynthetic process; IEA:Ensembl.
DR   GO; GO:0043312; P:neutrophil degranulation; TAS:Reactome.
DR   GO; GO:0006654; P:phosphatidic acid biosynthetic process; TAS:Reactome.
DR   GO; GO:0036151; P:phosphatidylcholine acyl-chain remodeling; IDA:UniProtKB.
DR   GO; GO:0006656; P:phosphatidylcholine biosynthetic process; TAS:Reactome.
DR   GO; GO:0036148; P:phosphatidylglycerol acyl-chain remodeling; TAS:Reactome.
DR   GO; GO:0008654; P:phospholipid biosynthetic process; ISS:UniProtKB.
DR   GO; GO:0045732; P:positive regulation of protein catabolic process; IEA:Ensembl.
DR   GO; GO:0060041; P:retina development in camera-type eye; IEA:Ensembl.
DR   GO; GO:0043129; P:surfactant homeostasis; IEA:Ensembl.
DR   GO; GO:0019432; P:triglyceride biosynthetic process; TAS:Reactome.
DR   InterPro; IPR011992; EF-hand-dom_pair.
DR   InterPro; IPR002048; EF_hand_dom.
DR   InterPro; IPR002123; Plipid/glycerol_acylTrfase.
DR   Pfam; PF01553; Acyltransferase; 1.
DR   Pfam; PF13833; EF-hand_8; 1.
DR   SMART; SM00054; EFh; 2.
DR   SMART; SM00563; PlsC; 1.
DR   SUPFAM; SSF47473; SSF47473; 1.
DR   PROSITE; PS50222; EF_HAND_2; 2.
PE   1: Evidence at protein level;
KW   Acyltransferase; Calcium; Complete proteome; Endoplasmic reticulum;
KW   Golgi apparatus; Lipid biosynthesis; Lipid droplet; Lipid metabolism;
KW   Membrane; Metal-binding; Phospholipid biosynthesis;
KW   Phospholipid metabolism; Reference proteome; Repeat; Signal-anchor;
KW   Transferase; Transmembrane; Transmembrane helix.
FT   CHAIN         1    534       Lysophosphatidylcholine acyltransferase
FT                                1.
FT                                /FTId=PRO_0000247064.
FT   TOPO_DOM      1     57       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     58     78       Helical; Signal-anchor for type II
FT                                membrane protein. {ECO:0000255}.
FT   TOPO_DOM     79    534       Lumenal. {ECO:0000255}.
FT   DOMAIN      379    414       EF-hand 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00448}.
FT   DOMAIN      451    486       EF-hand 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00448}.
FT   CA_BIND     392    403       1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00448}.
FT   MOTIF       135    140       HXXXXD motif.
FT   MOTIF       531    534       Di-lysine motif.
SQ   SEQUENCE   534 AA;  59151 MW;  69A9C3AEC698F6BD CRC64;
     MRLRGCGPRA APASSAGASD ARLLAPPGRN PFVHELRLSA LQKAQVALMT LTLFPVRLLV
     AAAMMLLAWP LALVASLGSA EKEPEQPPAL WRKVVDFLLK AIMRTMWFAG GFHRVAVKGR
     QALPTEAAIL TLAPHSSYFD AIPVTMTMSS IVMKAESRDI PIWGTLIQYI RPVFVSRSDQ
     DSRRKTVEEI KRRAQSNGKW PQIMIFPEGT CTNRTCLITF KPGAFIPGAP VQPVVLRYPN
     KLDTITWTWQ GPGALEILWL TLCQFHNQVE IEFLPVYSPS EEEKRNPALY ASNVRRVMAE
     ALGVSVTDYT FEDCQLALAE GQLRLPADTC LLEFARLVRG LGLKPEKLEK DLDRYSERAR
     MKGGEKIGIA EFAASLEVPV SDLLEDMFSL FDESGSGEVD LRECVVALSV VCRPARTLDT
     IQLAFKMYGA QEDGSVGEGD LSCILKTALG VAELTVTDLF RAIDQEEKGK ITFADFHRFA
     EMYPAFAEEY LYPDQTHFES CAETSPAPIP NGFCADFSPE NSDAGRKPVR KKLD
//
